Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07158658 · ClinicalTrials.gov registry record · NA

Prospective Case Series Evaluating the Efficacy and Safety of NeoThelium FT for Chronic Pressure Ulcers

A NA study of Pressure Injury, sponsored by NuScience Medical Biologics.

Recruiting
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT07158658 is a NA study of Pressure Injury that is actively recruiting participants, run by NuScience Medical Biologics. The registered enrollment target is 10 participants, below the 1,164-participant average among 6 other Pressure Injury trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07158658, a NA study of Pressure Injury, is actively recruiting participants, sponsored by NuScience Medical Biologics.

RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

This is a prospective case series evaluating the efficacy and safety of NeoThelium FT Amnion Skin Graft in the Mangement of Chronic Pressure Ulcers

Conditions Studied

Interventions

  • OTHER NeoThelium FT (HCT/P 361)

Study Locations (1)

Louisiana

  • MedCentris of Bossier City - Bossier City

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2025-12-01
Est. Completion 2026-05-01
Phase NA

Sponsor

NuScience Medical Biologics

7 total trials

What the Registry Record Tells You About NCT07158658

The ClinicalTrials.gov registry entry for NCT07158658 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,164-participant average among 6 other Pressure Injury trials with a reported enrollment target (99% lower). The listed sponsor is NuScience Medical Biologics, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pressure Injury appearing as the primary indexed condition, and to 1 intervention - of which NeoThelium FT (HCT/P 361) is the first listed.

NCT07158658 reports 1 study location spanning 1 distinct geographic area - top geographies include Louisiana.

Frequently Asked Questions

What is clinical trial NCT07158658 about?

NCT07158658 is a clinical study titled "Prospective Case Series Evaluating the Efficacy and Safety of NeoThelium FT for Chronic Pressure Ulcers". This is a prospective case series evaluating the efficacy and safety of NeoThelium FT Amnion Skin Graft in the Mangement of Chronic Pressure Ulcers

What is the current status of trial NCT07158658?

This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2025-12-01. Estimated completion is 2026-05-01.

What conditions does trial NCT07158658 study?

This clinical trial studies the following conditions: Pressure Injury.

What interventions are being tested in trial NCT07158658?

The interventions under investigation include: NeoThelium FT (HCT/P 361) (OTHER).

Who is sponsoring clinical trial NCT07158658?

This trial is sponsored by NuScience Medical Biologics, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07158658 being conducted?

This trial has 1 study location across Louisiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pressure Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.